Details
Stereochemistry | EPIMERIC |
Molecular Formula | C20H29NO3.ClH |
Molecular Weight | 367.91 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN1CCC[C@H](C1)OC(=O)C(O)(C2CCCCC2)C3=CC=CC=C3
InChI
InChIKey=LBKCCRHBZAWYOP-HUVSLODASA-N
InChI=1S/C20H29NO3.ClH/c1-21-14-8-13-18(15-21)24-19(22)20(23,16-9-4-2-5-10-16)17-11-6-3-7-12-17;/h2,4-5,9-10,17-18,23H,3,6-8,11-15H2,1H3;1H/t18-,20?;/m1./s1
Propenzolate is a pyridine derivative patented by National Research Development Corp. as an anticholinergic agent. Propenzolate is effective antidotes to the cholinesterase-inhibiting action of various organophosphorus compounds. In clinical trials, Propenzolate has an activity that decreases to some extent the secretion of hydrochloric acid and the volume of gastric juice. Adverse effects, including nausea, vomiting, weakness, and drowsiness, as well as xerostomia and cycloplegia, are observed in a high percentage of patients receiving 0.5 to 1.0 mg. every 12 hours.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13885723
0.5 to 1.0 mg. every 12 hours.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m438
Created by
admin on Fri Dec 15 19:08:49 GMT 2023 , Edited by admin on Fri Dec 15 19:08:49 GMT 2023
|
PRIMARY | Merck Index | ||
|
YCZ9J99C72
Created by
admin on Fri Dec 15 19:08:49 GMT 2023 , Edited by admin on Fri Dec 15 19:08:49 GMT 2023
|
PRIMARY | |||
|
CHEMBL2111025
Created by
admin on Fri Dec 15 19:08:49 GMT 2023 , Edited by admin on Fri Dec 15 19:08:49 GMT 2023
|
PRIMARY | |||
|
C170359
Created by
admin on Fri Dec 15 19:08:49 GMT 2023 , Edited by admin on Fri Dec 15 19:08:49 GMT 2023
|
PRIMARY | |||
|
DTXSID70931291
Created by
admin on Fri Dec 15 19:08:49 GMT 2023 , Edited by admin on Fri Dec 15 19:08:49 GMT 2023
|
PRIMARY | |||
|
118984356
Created by
admin on Fri Dec 15 19:08:49 GMT 2023 , Edited by admin on Fri Dec 15 19:08:49 GMT 2023
|
PRIMARY | |||
|
1420-03-7
Created by
admin on Fri Dec 15 19:08:49 GMT 2023 , Edited by admin on Fri Dec 15 19:08:49 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD